GLP-1 medications
Compounded Medications
Compounded Medications
Compounded Medications
When a drug is in shortage, compounders may be able to prepare a compounded version of that drug if they meet certain requirements in the Federal Food, Drug, and Cosmetic (FD&C) Act. As of May 2023, Ozempic and Wegovy are both listed on FDA’s Drug Shortages list.
Source: fda.gov
Semaglutide
Compounded Medications
Compounded Medications
Semaglutide belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists. It mimics the GLP-1 hormone that is released in the gastrointestinal tract in response to eating. One role of GLP-1 is to prompt the body to produce more insulin, which reduces blood glucose (sugar). GLP-1 in higher amounts also interacts with the parts of the brain that reduce appetite and signal a feeling of fullness.
Source: fda.gov
Tirzepatide
Compounded Medications
Tirzepatide
The U.S. Food and Drug Administration approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity (body mass index of 30 kilograms per square meter (kg/ m2) or greater) or overweight (body mass index of 27 kg/m2 or greater) with at least one weight-related condition (such as high blood pressure, type 2 diabetes or high cholesterol) for use, in addition to a reduced calorie diet and increased physical activity. Tirzepatide, the active ingredient in Zepbound, is already approved under the trade name Mounjaro to be used along with diet and exercise to help improve blood sugar (glucose) in adults with type 2 diabetes mellitus.
Source: fda.gov
when should i expect to start losing weight?
How much weight do you typically lose on Tirzepatide?
While everyone’s experience is unique, many people have lost 15% or more of their starting body weight with tirzepatide.
A clinical trial of over 2,500 people who are considered obese or overweight experienced significant weight loss in the first of tirzepatide’s weight loss studies. Those treated with tirzepatide had an average weight loss of 15% to 20% of their starting body weight over 72 weeks (about 16.5 months). This worked out to an average weight loss of 34 lbs. to 48 lbs. Those taking the placebo (an injection with no medication in it) only had an average of 3% weight loss.
What’s more, over a third of those taking the highest tirzepatide dose (15 mg per week) lost at least 25% of their starting body weight (over 58 lbs.).
Source goodrx.com
What is the best medication for me?
Weight loss medication comparison
Everyone's body is different and unique, it may take longer for some people to start noticing effects of the medications. Here is a comparison of popular weight loss drugs. At Care 2 U, we are continually researching to find the best and most effective medications for our clients to help them meet their weight-loss goals.
Source: goodrx.com